Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase NA 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 1052Neoplasms 886Prostatic Neoplasms 505Lung Neoplasms 422Colorectal Neoplasms 350Motor Activity 221Head and Neck Neoplasms 191Uterine Cervical Neoplasms 186Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 168Pancreatic Neoplasms 162Ovarian Neoplasms 139Colonic Neoplasms 138Carcinoma, Hepatocellular 134Anxiety Disorders 124Rectal Neoplasms 118Hematologic Neoplasms 114Multiple Myeloma 107Stomach Neoplasms 102Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 96Melanoma 92Depression 92Urinary Bladder Neoplasms 88Pain 88Endometrial Neoplasms 85Lymphoma 83Disease 83Glioblastoma 79Gastrointestinal Neoplasms 78

Interventions

Liquid Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neuroectodermal Tumors, Primitive, Peripheral × 1 year × Clear all
NCT06068075 2026-05-05

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Dana-Farber Cancer Institute

Phase NA Active not recruiting
340 enrolled
Sarcoma

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡